Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

BACKGROUND: Kidney transplantation is the preferred form of kidney replacement therapy for patients with end‐stage kidney disease (ESKD) and is often complicated by worsening or new‐onset diabetes. Management of hyperglycaemia is important to reduce post‐transplant and diabetes‐related complications...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cochrane Database Syst Rev
Главные авторы: Lo, Clement, Jun, Min, Badve, Sunil V, Pilmore, Helen, White, Sarah L, Hawley, Carmel, Cass, Alan, Perkovic, Vlado, Zoungas, Sophia
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Ltd 2017
Предметы:
Medicine General & Introductory Medical Sciences
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464265/
https://ncbi.nlm.nih.gov/pubmed/28238223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009966.pub2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы